is an oral inhibitor of the JAK 1 and JAK 2 tyrosine kinases. For the treatment of adult patients with polycythemia vera (PV) who are resistant to or intolerant of hydroxyurea and for the treatment of diseaserelated splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idio pathic myelofibrosis), post polycythemia vera myelofi
Tablets
36545 EGP
is an oral inhibitor of the JAK 1 and JAK 2 tyrosine kinases. For the treatment of adult patients with polycythemia vera (PV) who are resistant to or intolerant of hydroxyurea and for the treatment of diseaserelated splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idio pathic myelofibrosis), post polycythemia vera myelofi
Note: All the provided information about this drug does not substitute for consulting a doctor.